Investor Relations
IR News
- August 10, 2026
- Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP] / IR Materials
- June 26, 2026
- Notice of Resolutions at the 73rd Annual General Meeting of Shareholders / The 73rd Shareholders’ Newsletter
- June 3, 2026
- Notice of the 73rd Annual General Meeting of Shareholders
News Release
- August 13, 2026
- Impact on the NIPRO Group from the Earthquake in Colombia (326KB)
- August 4, 2026
- NIPRO Introduces Expanded Hemodialysis with ELISIO™-HX to U.S. Providers Following FDA Clearance (318KB)
Announcement of Spryte Medical, a US Affiliate of NIPRO, Completion of Subject Enrollment in the “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment (270KB) - July 30, 2026
- NIPRO CORPORATION Receives FDA 510(k) Clearance for ELISIO™-HX, Introducing HDs to the United States (195KB)
Financial Highlights
Management Philosophy
IR Calendar
